The present invention relates to a composition which comprises the following myelin basic protein peptides: MBP 30-44 MBP 83-99 MBP 131-145 and MBP 140-154. The composition may be used to treat a disease, in particular multiple sclerosis and/or optical neuritis and the invention also relates to such uses and methods.